BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ding L, Tang S, Wyatt TA, Knoell DL, Oupický D. Pulmonary siRNA delivery for lung disease: Review of recent progress and challenges. J Control Release 2021;330:977-91. [PMID: 33181203 DOI: 10.1016/j.jconrel.2020.11.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ma Z, Wong S, Forgham H, Esser L, Lai M, Leiske M, Kempe K, Sharbeen G, Youkhana J, Mansfeld F, Quinn J, Phillips P, Davis T, Kavallaris M, Mccarroll J. Aerosol delivery of star polymer-siRNA nanoparticles as a therapeutic strategy to inhibit lung tumor growth. Biomaterials 2022;285:121539. [DOI: 10.1016/j.biomaterials.2022.121539] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Wang J, Chen G, Liu N, Han X, Zhao F, Zhang L, Chen P. Strategies for improving the safety and RNAi efficacy of noncovalent peptide/siRNA nanocomplexes. Adv Colloid Interface Sci 2022;302:102638. [PMID: 35299136 DOI: 10.1016/j.cis.2022.102638] [Reference Citation Analysis]
3 Liu B, Ji Q, Cheng Y, Liu M, Zhang B, Mei Q, Liu D, Zhou S. Biomimetic GBM-targeted drug delivery system boosting ferroptosis for immunotherapy of orthotopic drug-resistant GBM. J Nanobiotechnology 2022;20:161. [PMID: 35351131 DOI: 10.1186/s12951-022-01360-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ding L, Tang S, Tang W, Mosley DD, Yu A, Sil D, Romanova S, Bailey KL, Knoell DL, Wyatt TA, Oupický D. Perfluorocarbon Nanoemulsions Enhance Therapeutic siRNA Delivery in the Treatment of Pulmonary Fibrosis. Adv Sci (Weinh) 2022;9:e2103676. [PMID: 34994102 DOI: 10.1002/advs.202103676] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Kunde SS, Ghosh R, Wairkar S. Emerging trends in pulmonary delivery of biopharmaceuticals. Drug Discov Today 2022:S1359-6446(22)00043-5. [PMID: 35143963 DOI: 10.1016/j.drudis.2022.02.003] [Reference Citation Analysis]
6 Zoulikha M, Xiao Q, Boafo GF, Sallam MA, Chen Z, He W. Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome. Acta Pharm Sin B 2022;12:600-20. [PMID: 34401226 DOI: 10.1016/j.apsb.2021.08.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 15.0] [Reference Citation Analysis]
7 Roh EH, Fromen CA, Sullivan MO. Inhalable mRNA vaccines for respiratory diseases: a roadmap. Curr Opin Biotechnol 2021;74:104-9. [PMID: 34894574 DOI: 10.1016/j.copbio.2021.10.017] [Reference Citation Analysis]
8 Ponkshe P, Feng S, Tan C. Inhalable liposomes for treating lung diseases: clinical development and challenges. Biomed Mater 2021;16. [PMID: 34134097 DOI: 10.1088/1748-605X/ac0c0c] [Cited by in F6Publishing: 1] [Reference Citation Analysis]